Lanean...
Recent Progress in the Prevention of Serogroup B Meningococcal Disease
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge of providing protection against serogroup B disease. Over a period of 4 decades, vaccine development has focused on subcapsular protein antigens, first with outer membrane vesicle (OMV) vaccines again...
Gorde:
| Argitaratua izan da: | Clin Vaccine Immunol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society for Microbiology
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5424234/ https://ncbi.nlm.nih.gov/pubmed/28356256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00566-16 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|